Trade Amarin Corporation plc - AMRN CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
| Spread | 0.0306 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Amarin Corporation PLC ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 0.9152 |
| Open* | 0.8955 |
| 1-Year Change* | -34.42% |
| Day's Range* | 0.862 - 0.8987 |
| 52 wk Range | 0.65-2.23 |
| Average Volume (10 days) | 4.02M |
| Average Volume (3 months) | 46.81M |
| Market Cap | 445.04M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 408.29M |
| Revenue | 322.44M |
| EPS | -0.13 |
| Dividend (Yield %) | N/A |
| Beta | 2.03 |
| Next Earnings Date | Feb 14, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 18, 2024 | 0.8620 | -0.0716 | -7.67% | 0.9336 | 0.9336 | 0.8333 |
| Apr 17, 2024 | 0.9152 | 0.0115 | 1.27% | 0.9037 | 0.9322 | 0.8939 |
| Apr 16, 2024 | 0.8821 | -0.0317 | -3.47% | 0.9138 | 0.9236 | 0.8821 |
| Apr 15, 2024 | 0.9042 | -0.0531 | -5.55% | 0.9573 | 0.9573 | 0.9018 |
| Apr 12, 2024 | 0.9596 | -0.0477 | -4.74% | 1.0073 | 1.0073 | 0.9445 |
| Apr 11, 2024 | 1.0073 | -0.0200 | -1.95% | 1.0273 | 1.0373 | 1.0073 |
| Apr 10, 2024 | 1.0373 | 0.0000 | 0.00% | 1.0373 | 1.0373 | 1.0073 |
| Apr 9, 2024 | 1.0473 | -0.0100 | -0.95% | 1.0573 | 1.0973 | 1.0373 |
| Apr 8, 2024 | 1.0673 | 0.0400 | 3.89% | 1.0273 | 1.0973 | 1.0273 |
| Apr 5, 2024 | 1.0173 | -0.0100 | -0.97% | 1.0273 | 1.0473 | 1.0073 |
| Apr 4, 2024 | 1.0373 | 0.0000 | 0.00% | 1.0373 | 1.0473 | 0.9973 |
| Apr 3, 2024 | 1.0473 | 0.0300 | 2.95% | 1.0173 | 1.0973 | 0.9873 |
| Apr 2, 2024 | 0.9826 | 0.1387 | 16.44% | 0.8439 | 0.9973 | 0.8367 |
| Apr 1, 2024 | 0.8774 | -0.0064 | -0.72% | 0.8838 | 0.9087 | 0.8460 |
| Mar 28, 2024 | 0.8681 | -0.0192 | -2.16% | 0.8873 | 0.9061 | 0.8428 |
| Mar 27, 2024 | 0.8754 | 0.0211 | 2.47% | 0.8543 | 0.9113 | 0.8427 |
| Mar 26, 2024 | 0.8573 | 0.0100 | 1.18% | 0.8473 | 0.8791 | 0.8473 |
| Mar 25, 2024 | 0.8398 | -0.0141 | -1.65% | 0.8539 | 0.8640 | 0.8279 |
| Mar 22, 2024 | 0.8474 | -0.0165 | -1.91% | 0.8639 | 0.8777 | 0.8375 |
| Mar 21, 2024 | 0.8503 | -0.0379 | -4.27% | 0.8882 | 0.9077 | 0.8503 |
Amarin Corporation plc Events
| Time (UTC) | Country | Event |
|---|---|---|
| Wednesday, May 1, 2024 | ||
| Time (UTC) 10:59 | Country IE
| Event Q1 2024 Amarin Corporation PLC Earnings Release Q1 2024 Amarin Corporation PLC Earnings ReleaseForecast -Previous - |
| Wednesday, July 31, 2024 | ||
| Time (UTC) 10:59 | Country IE
| Event Q2 2024 Amarin Corporation PLC Earnings Release Q2 2024 Amarin Corporation PLC Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 369.193 | 583.187 | 614.06 | 429.755 | 229.214 |
| Revenue | 369.193 | 583.187 | 614.06 | 429.755 | 229.214 |
| Cost of Revenue, Total | 108.631 | 121.327 | 131.444 | 96.019 | 54.543 |
| Gross Profit | 260.562 | 461.86 | 482.616 | 333.736 | 174.671 |
| Total Operating Expense | 475.062 | 572.685 | 633.715 | 454.034 | 337.439 |
| Selling/General/Admin. Expenses, Total | 304.416 | 408.334 | 463.312 | 323.623 | 226.996 |
| Research & Development | 30.411 | 29.307 | 38.959 | 34.392 | 55.2 |
| Unusual Expense (Income) | 31.604 | 13.717 | |||
| Operating Income | -105.869 | 10.502 | -19.655 | -24.279 | -108.225 |
| Interest Income (Expense), Net Non-Operating | 2.804 | 1.091 | 2.296 | 1.873 | -7.798 |
| Other, Net | -0.74 | -0.302 | 0.104 | -0.075 | -0.326 |
| Net Income Before Taxes | -103.805 | 11.291 | -17.255 | -22.481 | -116.349 |
| Net Income After Taxes | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Net Income Before Extra. Items | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Net Income | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Total Adjustments to Net Income | |||||
| Income Available to Common Excl. Extra. Items | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Income Available to Common Incl. Extra. Items | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Diluted Net Income | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Diluted Weighted Average Shares | 401.155 | 402.48 | 381.759 | 342.538 | 297.237 |
| Diluted EPS Excluding Extraordinary Items | -0.26375 | 0.0192 | -0.04715 | -0.06611 | -0.39176 |
| Diluted Normalized EPS | -0.21254 | 0.04253 | -0.04715 | -0.06611 | -0.39176 |
| Total Extraordinary Items | 0 | 0 | |||
| Depreciation / Amortization | 0.7 |
| Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|
| Total revenue | 80.167 | 85.975 | 90.245 | 89.878 | 94.44 |
| Revenue | 80.167 | 85.975 | 90.245 | 89.878 | 94.44 |
| Cost of Revenue, Total | 23.199 | 25.794 | 26.641 | 23.941 | 35.81 |
| Gross Profit | 56.968 | 60.181 | 63.604 | 65.937 | 58.63 |
| Total Operating Expense | 104.126 | 103.316 | 99.831 | 95.022 | 157.272 |
| Selling/General/Admin. Expenses, Total | 50.953 | 59.587 | 68.131 | 58.745 | 86.893 |
| Research & Development | 5.642 | 5.681 | 5.239 | 5.765 | 9.356 |
| Operating Income | -23.959 | -17.341 | -9.586 | -5.144 | -62.832 |
| Interest Income (Expense), Net Non-Operating | 3.001 | 2.221 | 1.563 | 0.75 | 0.288 |
| Other, Net | 3.043 | 0.624 | 1.25 | 0.511 | -2.255 |
| Net Income Before Taxes | -17.915 | -14.496 | -6.773 | -3.883 | -64.799 |
| Net Income After Taxes | -17.56 | -16.46 | 0.856 | -5.14 | -69.956 |
| Net Income Before Extra. Items | -17.56 | -16.46 | 0.856 | -5.14 | -69.956 |
| Net Income | -17.56 | -16.46 | 0.856 | -5.14 | -69.956 |
| Income Available to Common Excl. Extra. Items | -17.56 | -16.46 | 0.856 | -5.14 | -69.956 |
| Income Available to Common Incl. Extra. Items | -17.56 | -16.46 | 0.856 | -5.14 | -69.956 |
| Diluted Net Income | -17.56 | -16.46 | 0.856 | -5.14 | -69.956 |
| Diluted Weighted Average Shares | 407.848 | 406.177 | 404.788 | 404.614 | 398.187 |
| Diluted EPS Excluding Extraordinary Items | -0.04306 | -0.04052 | 0.00211 | -0.0127 | -0.17569 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.00428 | -0.02091 | 0.00183 | -0.00215 | -0.13453 |
| Unusual Expense (Income) | 24.332 | 12.254 | -0.18 | 6.571 | 25.213 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 689.098 | 878.727 | 879.233 | 855.005 | 377.997 |
| Cash and Short Term Investments | 309.361 | 454.128 | 500.933 | 644.588 | 249.227 |
| Cash & Equivalents | 217.666 | 219.454 | 186.964 | 644.588 | 249.227 |
| Total Receivables, Net | 130.99 | 163.653 | 154.574 | 116.43 | 66.523 |
| Accounts Receivable - Trade, Net | 130.99 | 163.653 | 154.574 | 116.43 | 66.523 |
| Total Inventory | 228.732 | 234.676 | 188.864 | 76.769 | 57.802 |
| Prepaid Expenses | 19.492 | 22.352 | 30.947 | 13.311 | 2.945 |
| Other Current Assets, Total | 0.523 | 3.918 | 3.915 | 3.907 | 1.5 |
| Total Assets | 886.179 | 1068.06 | 966.021 | 882.209 | 385.714 |
| Property/Plant/Equipment, Total - Net | 9.948 | 9.085 | 10.07 | 10.872 | 0.063 |
| Property/Plant/Equipment, Total - Gross | 12.42 | 11.006 | 11.686 | 11.891 | 0.902 |
| Accumulated Depreciation, Total | -2.472 | -1.921 | -1.616 | -1.019 | -0.839 |
| Intangibles, Net | 21.78 | 23.547 | 13.817 | 15.258 | 7.48 |
| Other Long Term Assets, Total | 164.078 | 121.71 | 0.432 | 1.074 | 0.174 |
| Total Current Liabilities | 259.479 | 370.682 | 307.443 | 242.248 | 157.263 |
| Accounts Payable | 64.602 | 114.922 | 105.876 | 49.95 | 37.632 |
| Accrued Expenses | 157.035 | 207.509 | 169.855 | 123.24 | 76.459 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0 | 50.13 | 34.24 | ||
| Other Current Liabilities, Total | 37.842 | 48.251 | 31.712 | 18.928 | 8.932 |
| Total Liabilities | 290.846 | 400.966 | 338.516 | 273.946 | 233.384 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 46.108 |
| Long Term Debt | 0 | 46.108 | |||
| Other Liabilities, Total | 31.367 | 30.284 | 31.073 | 31.698 | 30.013 |
| Total Equity | 595.333 | 667.099 | 627.505 | 608.263 | 152.33 |
| Redeemable Preferred Stock | 0 | 21.85 | 21.85 | ||
| Common Stock | 299.002 | 294.027 | 290.115 | 269.173 | 246.663 |
| Additional Paid-In Capital | 1885.35 | 1855.25 | 1817.65 | 1764.32 | 1282.76 |
| Retained Earnings (Accumulated Deficit) | -1527.25 | -1421.45 | -1429.18 | -1411.18 | -1388.53 |
| Treasury Stock - Common | -61.77 | -60.726 | -51.082 | -35.9 | -10.413 |
| Total Liabilities & Shareholders’ Equity | 886.179 | 1068.06 | 966.021 | 882.209 | 385.714 |
| Total Common Shares Outstanding | 404.346 | 396.598 | 392.538 | 360.104 | 325.85 |
| Total Preferred Shares Outstanding | 0 | 289.317 | 289.317 | ||
| Short Term Investments | 91.695 | 234.674 | 313.969 | ||
| Long Term Investments | 1.275 | 34.996 | 62.469 |
| Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 717.511 | 706.495 | 683.821 | 689.098 | 686.52 |
| Cash and Short Term Investments | 320.662 | 312.914 | 304.371 | 309.361 | 303.701 |
| Cash & Equivalents | 270.814 | 232.995 | 191.412 | 217.666 | 240.498 |
| Short Term Investments | 49.848 | 79.919 | 112.959 | 91.695 | 63.203 |
| Total Receivables, Net | 122.4 | 122.73 | 133.236 | 130.99 | 123.379 |
| Accounts Receivable - Trade, Net | 122.4 | 122.73 | 133.236 | 130.99 | 123.379 |
| Total Inventory | 254.461 | 227.021 | 225.813 | 228.732 | 227.606 |
| Prepaid Expenses | 19.464 | 43.306 | 19.878 | 19.492 | 27.914 |
| Other Current Assets, Total | 0.524 | 0.524 | 0.523 | 0.523 | 3.92 |
| Total Assets | 839.031 | 860.018 | 860.188 | 886.179 | 908.303 |
| Property/Plant/Equipment, Total - Net | 8.657 | 9.157 | 9.377 | 9.948 | 9.461 |
| Intangibles, Net | 19.676 | 20.377 | 21.078 | 21.78 | 21.638 |
| Long Term Investments | 0 | 0.067 | 0.544 | 1.275 | 2.264 |
| Other Long Term Assets, Total | 93.187 | 123.922 | 145.368 | 164.078 | 188.42 |
| Total Current Liabilities | 266.691 | 270.932 | 244.242 | 259.479 | 287.356 |
| Accounts Payable | 53.362 | 54.309 | 58.779 | 64.602 | 93.157 |
| Accrued Expenses | 211.304 | 214.598 | 183.264 | 192.678 | 192.001 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 2.025 | 2.025 | 2.199 | 2.199 | 2.198 |
| Total Liabilities | 285.883 | 290.89 | 275.395 | 290.846 | 320.476 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 19.192 | 19.958 | 31.153 | 31.367 | 33.12 |
| Total Equity | 553.148 | 569.128 | 584.793 | 595.333 | 587.827 |
| Common Stock | 302.318 | 301.906 | 301.285 | 299.002 | 298.596 |
| Additional Paid-In Capital | 1895.16 | 1891.96 | 1890.5 | 1885.35 | 1878.92 |
| Retained Earnings (Accumulated Deficit) | -1580.58 | -1561.27 | -1543.71 | -1527.25 | -1528.11 |
| Treasury Stock - Common | -63.743 | -63.464 | -63.277 | -61.77 | -61.585 |
| Total Liabilities & Shareholders’ Equity | 839.031 | 860.018 | 860.188 | 886.179 | 908.303 |
| Total Common Shares Outstanding | 408.551 | 408.134 | 407.266 | 404.346 | 403.829 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -105.803 | 7.729 | -18 | -22.645 | -116.445 |
| Cash From Operating Activities | -180.092 | -66.537 | -21.746 | -9.366 | -94.703 |
| Cash From Operating Activities | 0.551 | 0.587 | 0.597 | 0.18 | 0.023 |
| Amortization | 2.545 | 2.27 | 1.441 | 0.679 | 0.646 |
| Deferred Taxes | 0 | ||||
| Non-Cash Items | 26.686 | 38.867 | 48.05 | 32.561 | 20.989 |
| Cash Taxes Paid | -1.782 | 3.656 | 0.207 | 0.067 | 0.85 |
| Cash Interest Paid | 0 | 2.043 | 4.591 | 21.527 | |
| Changes in Working Capital | -104.071 | -115.99 | -53.834 | -20.141 | 0.084 |
| Cash From Investing Activities | 175.288 | 104.103 | -376.963 | -2.478 | -0.058 |
| Capital Expenditures | -0.599 | -0.252 | -2.478 | -0.058 | |
| Cash From Financing Activities | -0.379 | -5.073 | -58.907 | 409.612 | 271.251 |
| Financing Cash Flow Items | -1.044 | -9.644 | -15.686 | -25.487 | -6.344 |
| Issuance (Retirement) of Stock, Net | 0.665 | 4.571 | 7.115 | 466.751 | 292.285 |
| Issuance (Retirement) of Debt, Net | -50.336 | -31.652 | -14.69 | ||
| Net Change in Cash | -5.183 | 32.493 | -457.616 | 397.768 | 176.49 |
| Other Investing Cash Flow Items, Total | 175.887 | 104.103 | -376.711 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -16.46 | -105.803 | -106.659 | -101.519 | -31.563 |
| Cash From Operating Activities | -7.008 | -180.092 | -181.644 | -163.431 | -98.847 |
| Cash From Operating Activities | 0.063 | 0.551 | 0.426 | 0.288 | 0.144 |
| Amortization | 0.702 | 2.545 | 1.909 | 1.273 | 0.636 |
| Non-Cash Items | 4.649 | 26.686 | 20.358 | 15.299 | 6.452 |
| Cash Taxes Paid | 0.038 | -1.782 | -1.49 | -2.112 | 0.051 |
| Cash Interest Paid | |||||
| Changes in Working Capital | 4.038 | -104.071 | -97.678 | -78.772 | -74.516 |
| Cash From Investing Activities | -19.61 | 175.288 | 203.107 | 172.239 | 99.049 |
| Capital Expenditures | -0.599 | ||||
| Other Investing Cash Flow Items, Total | -19.61 | 175.887 | 203.107 | 172.239 | 99.049 |
| Cash From Financing Activities | 0.364 | -0.379 | -0.417 | -0.261 | -0.505 |
| Financing Cash Flow Items | -1.507 | -1.044 | -0.859 | -0.693 | -0.535 |
| Issuance (Retirement) of Stock, Net | 1.871 | 0.665 | 0.442 | 0.432 | 0.03 |
| Issuance (Retirement) of Debt, Net | |||||
| Net Change in Cash | -26.254 | -5.183 | 21.046 | 8.547 | -0.303 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Amarin Corporation plc Company profile
Amarin Corporation (AMRN) is a clinical-stage biopharmaceutical company focused on the commercialisation and improvement of therapeutics to cure and deal with cardiovascular diseases.
Established in 1989, Amarin is headquartered in Dublin, Ireland, and operates in several European countries, the United States, Canada, Lebanon and the United Arab Emirates.
The company’s lead commercial product VASCEPA (icosapent ethyl) is a prescription-only omega-3 fatty acid product. Taken as an adjunct to diet, it reduces triglyceride levels in adult patients suffering from severe hypertriglyceridemia. The drug helps to address cardiovascular risk for millions of patients.
VASCEPA was launched in the United States in 2013, but gained wider recognition in 2019 as the US Food and Drug Administration (FDA) approved Amarin for a broader indication for cardiovascular risk reduction in studied high-risk patients. It has also got approval from the European Commission to reduce the risks for cardiac patients.
Amarin still prices VASCEPA at a considerably lower level than other new drugs of its category.
Formerly known as Ethical Holdings, the company changed its name to Amarin Corporation in 1999. The company went public in July 2019. It trades on the Nasdaq under the ticker ‘AMRN’.
| Industry: | Bio Therapeutic Drugs |
First Floor, Block 3, The Oval,
Shelbourne Road, Ballsbridge
DUBLIN
IE
Income Statement
- Annual
- Quarterly
News
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024
Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com